<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01747395</url>
  </required_header>
  <id_info>
    <org_study_id>ICRESP814/10</org_study_id>
    <nct_id>NCT01747395</nct_id>
  </id_info>
  <brief_title>Exercise Training Associated With Inspiratory Muscle Training in Heart Failure</brief_title>
  <official_title>Effects of Aerobic Exercise Training Associated With Inspiratory Muscle Training in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that aerobic exercise training associated with respiratory
      muscle training will cause additional benefits compared to isolated exercise training or
      respiratory training in chronic heart failure patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that aerobic exercise training associated with respiratory
      muscle training will cause additional benefits in the autonomic control and respiratory
      function compared to isolated exercise training or respiratory training in chronic heart
      failure patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Autonomic control</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will reduce sympathetic nerve activity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will improve peak oxygen consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will improve quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood inflammatory markers</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will reduces blood inflammatory markers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular evaluation</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will increase skeletal muscle strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratoy muscle function</measure>
    <time_frame>4 months</time_frame>
    <description>Exercise training associated with inspiratory muscle training will increase inspitarory muscle strength and endurance.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No exercise group (sedentary)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic Exercise Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group undergoing isolate aerobic exercise training 3 times/week, during 40 minutes, for 04 mouths</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group undergoing isolate inspiratory muscle training 7 times/week, during 30 minutes, for 04 mouths</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic+Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group undergoing aerobic exercise training (3 times/week during 40 minutes) associate inspiratory muscle training (7 times/week during 30 minutes) for 04 mounths</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training</intervention_name>
    <description>The heart failure patients are subjected to differents protocols of physical training</description>
    <arm_group_label>Aerobic Exercise Training</arm_group_label>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_label>Aerobic+Inspiratory Muscle Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systolic heart failure and New York Heart Association (NYHA) class
             II-III

          -  Left ventricular ejection fraction less than 40%

          -  Peak Oxygen Consumption less than 20 ml/Kg/min

        Exclusion Criteria:

          -  Chronic Obstructive Pulmonary Disease

          -  Neuromuscular, Orthopedic, Neurologic and Neoplastic Diseases

          -  Recent myocardial infarction or cardiac surgery (less than 6 months)

          -  Unstable angina pectoris

          -  Atrial Fibrillation

          -  Pacemakers users

          -  Actual Smoker

          -  Pregnant

          -  Changing medication or hospital admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Eduardo Negrão</last_name>
    <role>Principal Investigator</role>
    <affiliation>InCor, HCFMUSP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Eduardo Negrão</last_name>
    <phone>21 11 26615699</phone>
    <email>cndnegrao@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Fernandes Trevizan</last_name>
    <phone>21 11 2661 5099</phone>
    <email>patricia_trevizan@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto do Coração - HC/FMUSP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Trevizan</last_name>
      <phone>21 11 2661 5099</phone>
      <email>patricia_trevizan@yahoo.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2012</study_first_submitted>
  <study_first_submitted_qc>December 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2012</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Patricia Fernandes Trevizan</investigator_full_name>
    <investigator_title>BS</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Exercise and Physical Fitness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

